"If taking medications that decrease appetite or insulin requirements, people with type 1 diabetes still must continue taking their long-acting insulin or using their insulin pump." Semaglutide, vomiting, and DKA: A case study In a 2023 case report, a person with type 1 arrived at an emergency room with ketoacidosis, after suffering nausea and vomiting attributed to taking Wegovy (semaglutide) prescribed by his endocrinologist for weight loss
Because formulations vary, it is important to use a sublingual GLP-1 product as part of a structured, physician-guided program rather than assuming all products behave identically
Antioxidants are major in vivo and in situ defense mechanisms of the cells against oxidative stress [9, 13, 1517]
doi: 10.1089/ars.2012.5149 195 MohammadiH.ShamshirianA.EslamiS.ShamshirianD.EbrahimzadehM
Rapid weight loss and the reversal of insulin resistance post-surgery may lead to heightened tissue sensitivity to insulin, thereby contributing to hypoglycemia